搜尋
市場行情
自選股
新聞
分析
交易工具
選股工具
掃碼下載
一鍵診股 讓投資更聰明
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
登入
免費註冊
搜尋
免費註冊
市場行情
/
股票
/
醫藥與醫學研究
/
生物技術與醫療研究
/
cnsp
/
財務摘要
CNS Pharmaceuticals Inc
CNSP
添加自選
5.110
USD
-0.010
-0.20%
收盤 09-18 16:00(美東)
7.47M
總市值
虧損
本益比TTM
CNS Pharmaceuticals Inc
5.110
-0.010
-0.20%
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
財報
公司估值
風險評估
概覽
新聞分析
財務
股票評分
技術分析
預測
持股情況
股息
公司資料
財務摘要
利潤表
資產負債表
現金流量表
財報
公司估值
風險評估
CNSP 財務數據
透過專為投資者打造的一站式數據看板,全面查看 CNS Pharmaceuticals Inc 的財務狀況。平台將複雜的財務報表整理為可自定義的視圖,助您更輕鬆地進行財務分析。您可以查看最新年度財務報告,也可以通過利潤表、資產負債表和現金流量表,按季度分析公司表現。借助實時財務指標,持續追蹤公司的經營狀況和市場表現更加便捷。
關鍵財務比率
總市值
7.47M
股利TTM
0.00
本益比TTM
-0.21
每股盈餘TTM
-24.12
營業收入
--
淨利潤
-14.86M
淨資產收益率
-298.64%
總資產收益率
-179.17%
CNS Pharmaceuticals Inc 財報行事曆
最新發布
8月 12, 2026
每股收益 / 預測值
-0.38
/-0.24
營業收入 / 預測值
--
/0.00
財務報表摘要
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
財務指標
每股收益
94.10%
-0.38
61.43%
-7.30
90.27%
-9.70
96.20%
-5.76
99.84%
-6.42
99.84%
-18.93
99.69%
-99.72
99.53%
-151.64
87.04%
-4.03K
84.27%
-12.21K
71.51%
-31.70K
--
-32.48K
--
-31.11K
--
-77.61K
--
-111.29K
--
--
--
--
--
--
--
--
--
--
淨利潤
-8.97%
-2.59M
-14.78%
-4.94M
-87.50%
-5.96M
42.59%
-3.22M
6.16%
-2.37M
-21.34%
-4.30M
40.91%
-3.18M
-23.95%
-5.61M
37.07%
-2.53M
28.13%
-3.54M
2.34%
-5.38M
-32.26%
-4.52M
-12.77%
-4.02M
-56.48%
-4.93M
-69.17%
-5.50M
10.35%
-3.42M
6.50%
-3.57M
12.78%
-3.15M
-8.28%
-3.25M
-89.67%
-3.81M
資產負債率
-100.00%
0.00%
225.89%
4.99%
1.67%
3.81%
-38.37%
0.26%
-83.18%
0.84%
-88.06%
1.53%
-78.81%
3.75%
-76.62%
0.42%
93.52%
4.99%
229.11%
12.83%
463.10%
17.69%
--
1.80%
--
2.58%
--
3.90%
--
3.14%
--
--
--
--
--
--
--
--
--
--
利潤表
營業利潤
-12.06%
-2.70M
-14.70%
-4.98M
-87.06%
-5.99M
42.20%
-3.25M
4.70%
-2.41M
-22.36%
-4.34M
40.51%
-3.20M
-24.15%
-5.63M
37.20%
-2.53M
28.05%
-3.54M
2.23%
-5.38M
-32.61%
-4.53M
-12.93%
-4.03M
-56.44%
-4.93M
-69.21%
-5.50M
10.34%
-3.42M
6.48%
-3.56M
12.76%
-3.15M
-8.33%
-3.25M
-89.62%
-3.81M
淨利潤
-8.97%
-2.59M
-14.78%
-4.94M
-87.50%
-5.96M
42.59%
-3.22M
6.16%
-2.37M
-21.34%
-4.30M
40.91%
-3.18M
-23.95%
-5.61M
37.07%
-2.53M
28.13%
-3.54M
2.34%
-5.38M
-32.26%
-4.52M
-12.77%
-4.02M
-56.48%
-4.93M
-69.17%
-5.50M
10.35%
-3.42M
6.50%
-3.57M
12.78%
-3.15M
-8.28%
-3.25M
-89.67%
-3.81M
資產負債表
流動資產
55.07%
21.92M
-70.28%
4.08M
-6.42%
8.10M
54.19%
11.39M
558.98%
14.14M
756.94%
13.72M
444.16%
8.66M
258.32%
7.39M
-64.66%
2.15M
-77.03%
1.60M
-87.34%
1.59M
-76.30%
2.06M
-46.73%
6.07M
-52.68%
6.97M
68.03%
12.56M
-22.01%
8.70M
-17.91%
11.40M
15.23%
14.73M
-51.75%
7.48M
343.36%
11.16M
流動負債總額
170.30%
3.74M
64.89%
4.58M
62.46%
4.10M
-51.71%
1.96M
-79.55%
1.38M
-54.38%
2.78M
-58.84%
2.52M
-0.29%
4.06M
69.19%
6.76M
55.28%
6.09M
24.65%
6.13M
226.99%
4.07M
332.66%
4.00M
266.87%
3.92M
89.66%
4.92M
-48.31%
1.24M
-49.54%
923.86K
-43.77%
1.07M
36.15%
2.59M
371.32%
2.41M
總資產
51.21%
21.94M
-66.16%
4.65M
-0.89%
8.62M
60.19%
11.87M
487.54%
14.51M
727.83%
13.75M
411.56%
8.70M
218.26%
7.41M
-61.73%
2.47M
-77.60%
1.66M
-86.97%
1.70M
-75.84%
2.33M
-48.17%
6.45M
-53.28%
7.41M
49.05%
13.05M
-16.25%
9.64M
-12.58%
12.45M
20.75%
15.87M
-44.76%
8.76M
285.48%
11.51M
總負債
170.30%
3.74M
64.89%
4.58M
62.46%
4.10M
-51.71%
1.96M
-79.55%
1.38M
-54.38%
2.78M
-58.84%
2.52M
-0.29%
4.06M
69.19%
6.76M
55.28%
6.09M
24.65%
6.13M
226.99%
4.07M
332.66%
4.00M
266.87%
3.92M
89.66%
4.92M
-48.31%
1.24M
-49.54%
923.86K
-43.77%
1.07M
36.15%
2.59M
371.32%
2.41M
總權益
38.67%
18.20M
-99.36%
70.70K
-26.78%
4.52M
195.62%
9.91M
405.69%
13.12M
347.60%
10.97M
239.36%
6.18M
292.58%
3.35M
-274.93%
-4.29M
-226.88%
-4.43M
-154.50%
-4.43M
-120.74%
-1.74M
-78.70%
2.45M
-76.41%
3.49M
31.96%
8.13M
-7.76%
8.39M
-7.13%
11.52M
31.66%
14.80M
-55.81%
6.16M
267.76%
9.10M
現金流量表
經營淨額
33.76%
-3.54M
-43.39%
-4.65M
44.22%
-3.05M
68.03%
-2.17M
-223.76%
-5.34M
-1.56%
-3.24M
-115.70%
-5.47M
-101.40%
-6.80M
51.50%
-1.65M
33.84%
-3.19M
-10.02%
-2.54M
-86.25%
-3.38M
-1.20%
-3.40M
-56.79%
-4.82M
28.78%
-2.31M
9.16%
-1.81M
32.72%
-3.36M
6.98%
-3.08M
-123.73%
-3.24M
-56.67%
-2.00M
投資淨額
--
-3.82K
--
-6.18K
-333.98%
-18.18K
--
--
--
--
--
--
-94.16%
-4.19K
--
--
--
--
--
--
-215800.00%
-2.16K
-15.19%
-1.74K
--
--
--
--
100.05%
1.00
--
-1.51K
--
-2.91K
100.00%
0.00
--
-2.08K
--
0.00
融資淨額
364.97%
20.58M
-95.88%
404.66K
-91.80%
406.87K
-100.75%
-91.62K
90.20%
4.43M
184.17%
9.83M
127.92%
4.96M
146826.13%
12.28M
-9.52%
2.33M
2975.33%
3.46M
-59.17%
2.18M
107.14%
8.36K
2313.46%
2.57M
-101.14%
-120.28K
6538.96%
5.33M
-103.41%
-117.14K
-114.37%
-116.17K
2925.97%
10.51M
-100.58%
-82.83K
7735.92%
3.44M
常見問題
CNS Pharmaceuticals Inc的流動資產是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,流動資產為8.10M(同比變化-6.42)。
CNS Pharmaceuticals Inc的總資產是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的總資產為8.62M(同比變化-0.89)。
CNS Pharmaceuticals Inc的總負債是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的總責任為4.10M(同比變化62.46)。
CNS Pharmaceuticals Inc的總權益是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的總權益為4.52M(同比變化-26.78)。
CNS Pharmaceuticals Inc的淨營業收入是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的淨營業收入為-15.99M(同比變化-7.28)。
CNS Pharmaceuticals Inc的淨投資是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的淨投資為-18.18K(同比變化-333.98)。
CNS Pharmaceuticals Inc的淨融資是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,CNS Pharmaceuticals Inc的淨融資為14.57M(同比變化-36.74)。
CNS Pharmaceuticals Inc的每股收益(EPS)是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,每股收益(EPS)為-35.75(同比變化92.34)。
CNS Pharmaceuticals Inc的淨利潤是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,淨利潤為-15.85M(同比變化-6.68)。
CNS Pharmaceuticals Inc的債務與資產比率是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,債務與資產比率為3.81(同比變化1.67)。
CNS Pharmaceuticals Inc的股東權益回報率(ROE)是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,股東權益回報率(ROE)為-296.30(同比變化82.61)。
CNS Pharmaceuticals Inc的資產回報率(ROA)是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,資產回報率(ROA)為-182.99(同比變化35.95)。
CNS Pharmaceuticals Inc的營業利潤是多少?
根據CNS Pharmaceuticals Inc的FY2025財報,營業利潤為-15.99M(同比變化-7.28)。